Singulair and Warm type haemolytic anaemia - a phase IV clinical study of FDA data

Summary:

Warm type haemolytic anaemia is reported only by a few people who take Singulair.

The phase IV clinical study analyzes which people take Singulair and have Warm type haemolytic anaemia. It is created by eHealthMe based on reports of 111,364 people who have side effects while taking Singulair from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 21, 2023

111,364 people reported to have side effects when taking Singulair.
Among them, 1 person (0.0%) has Warm type haemolytic anaemia.

What is Singulair?

Singulair has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 115,425 Singulair users for its effectiveness, alternative drugs and more.

What is Warm type haemolytic anaemia?

Warm type haemolytic anaemia (red cell destruction due to warm antibody self defence) is found to be associated with 176 drugs and 122 conditions by eHealthMe.

Number of Singulair and Warm type haemolytic anaemia reports submitted per year:

Could Singulair cause Warm type haemolytic anaemia?

Gender of people who have Warm type haemolytic anaemia when taking Singulair *:

female: 0.0 %
male: 100 %

Age of people who have Warm type haemolytic anaemia when taking Singulair *:

Common side effects people have besides Warm type haemolytic anaemia *:

Overdose: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Singulair and have Warm type haemolytic anaemia?

Check whether Warm type haemolytic anaemia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .

Related studies

How severe was Warm type haemolytic anaemia and when was it recovered:

Warm type haemolytic anaemia in Singulair

Expand to all the drugs that have ingredients of montelukast sodium:

Warm type haemolytic anaemia and drugs with ingredients of montelukast sodium (3 reports)

Alternative drugs to, pros and cons of Singulair:

Singulair (115,425 reports)

Common Singulair side effects:

Asthma: 15,229 reports
Breathing difficulty: 14,467 reports
Cough: 9,131 reports
Fatigue (feeling of tiredness): 9,051 reports
Headache (pain in head): 7,885 reports
Drug ineffective: 7,681 reports
Wheezing (a high-pitched whistling sound made while you breath): 7,374 reports

Browse all side effects of Singulair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Warm type haemolytic anaemia treatments and more:

Warm type haemolytic anaemia (205 reports)

COVID vaccines that are related to Warm type haemolytic anaemia:

All the drugs that are associated with Warm type haemolytic anaemia:

Warm type haemolytic anaemia (176 drugs)

All the conditions that are associated with Warm type haemolytic anaemia:

Warm type haemolytic anaemia (122 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on montelukast sodium (the active ingredients of Singulair) and Singulair (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.